HLN: Haleon plc - Summary | Jitta

Haleon plc

NYSE:HLN

Price
$8.15
Loss Chance
49.5%
4.41JITTA SCORE
74.27%Over Jitta Line
Jitta Ranking
1,549 / 5,069
Grow your money with Jitta Ranking. See details.
HISTORICAL JITTA SCORE
Jitta Factors
Growth Opportunity (27)
Recent Business Performance (57)
Financial Strength (51)
Return to Shareholders (12)
Competitive Advantage (49)
Jitta Signs
Recent IPOLess than 3 years
Recent Business PerformanceEarning decline 18.36% in the last year
Key Stats
Jitta Score
Jitta Line
4.41
74.27%
3.88
191.80%
Personal Care Products
5.20
215.19%
6.09
373.28%
4.20
7.48%
COMPANY DESCRIPTION
Haleon plc, together with its subsidiaries, engages in the research, development, manufacture, and sale of various consumer healthcare products in North America, Europe, the Middle East, Africa, Latin America, and the Asia Pacific. The company provides oral health, pain relief, respiratory health, digestive health, and other products, as well as vitamins, minerals, and supplements. Its portfolio of brands includes Advil, Sensodyne, Panadol, Voltaren, Theraflu, Otrivin, Polident, parodontax, and Centrum. The company was formerly known as DRVW 2022 plc and changed its name to Haleon plc in February 2022. Haleon plc was incorporated in 2021 and is headquartered in Weybridge, the United Kingdom.